Robotic rehab may retrain the brain's sense of vertical after stroke

NCT ID NCT07023770

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests whether a 3-week rehabilitation program using an exoskeleton can help people who have had a stroke correct a condition called lateropulsion, where the body leans to one side due to a distorted sense of vertical. Participants will receive 15 sessions combining exoskeleton-assisted balance exercises with physiotherapy focused on upright orientation. The study measures changes in how accurately participants perceive verticality, which is key to balance and walking.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 3-week rehabilitation program combining exoskeleton-assisted balance and gait exercises with physiotherapy focused on vertical body orientation.
What this could lead to
If it works, this could point toward a more effective rehab approach to help stroke survivors with lateropulsion regain balance and upright posture.
What could go wrong
This is a very small pilot study with only 3 participants, so results may not apply broadly. The program is intensive and may not be feasible for all stroke patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 84 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Right hemispheric first and unique ischemic stroke between 2 weeks and 6 months old (subacute phase) ; * Presence of lateropulsion, assessed by the Scale for Contraversive Pushing (2 ≤ SCP \< 5) * Presence of contralesional VV bias (VV \> 4°) * Right handedness defined by a Edinburgh score ≥0,39 * Being hospitalized in a Physical Medicine and Neurological Rehabilitation (PMR) facility. * Have given a written and informed consent Exclusion Criteria: * Medical instability making evaluation impossible, * Comprehension or cognitive or behavioral disorders, or depressive symptoms that compromise participation in the program * Postural disorders or body geometry disorders that interfere with balance for a reason that is independant of the stroke * Morphological contraindications to the use of the Atalante® robot (segment length or joint ranges; height \<155cm; weight \>100kg), * Severe spasticity (\>3 on the modified Ashworth scale) in the adductors, quadriceps, hamstrings and triceps surae * Presence of a pressure sore at the areas of contact with the Atalante® robot, * History of osteoporotic fractures. * Pregnancy and breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke, ischemic are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Grenoble University Hospital

    RECRUITING

    Échirolles, France

  • Grenoble University Hospital

    RECRUITING

    Grenoble, 38043, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.